Geode Capital Management’s Vaxcyte PCVX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $97.9M | Buy |
3,011,140
+142,086
| +5% | +$4.62M | 0.01% | 1041 |
|
2025
Q1 | $108M | Buy |
2,869,054
+66,166
| +2% | +$2.5M | 0.01% | 934 |
|
2024
Q4 | $229M | Buy |
2,802,888
+102,106
| +4% | +$8.36M | 0.02% | 589 |
|
2024
Q3 | $309M | Buy |
2,700,782
+259,010
| +11% | +$29.6M | 0.03% | 510 |
|
2024
Q2 | $184M | Buy |
2,441,772
+154,397
| +7% | +$11.7M | 0.02% | 623 |
|
2024
Q1 | $156M | Buy |
2,287,375
+313,869
| +16% | +$21.4M | 0.01% | 693 |
|
2023
Q4 | $124M | Buy |
1,973,506
+98,392
| +5% | +$6.18M | 0.01% | 745 |
|
2023
Q3 | $95.6M | Buy |
1,875,114
+189,900
| +11% | +$9.68M | 0.01% | 823 |
|
2023
Q2 | $84.2M | Buy |
1,685,214
+355,875
| +27% | +$17.8M | 0.01% | 898 |
|
2023
Q1 | $49.8M | Buy |
1,329,339
+77,906
| +6% | +$2.92M | 0.01% | 1190 |
|
2022
Q4 | $60M | Buy |
1,251,433
+356,647
| +40% | +$17.1M | 0.01% | 1026 |
|
2022
Q3 | $21.5M | Buy |
894,786
+115,091
| +15% | +$2.76M | ﹤0.01% | 1675 |
|
2022
Q2 | $17M | Buy |
779,695
+57,732
| +8% | +$1.26M | ﹤0.01% | 1871 |
|
2022
Q1 | $17.4M | Buy |
721,963
+66,246
| +10% | +$1.6M | ﹤0.01% | 1987 |
|
2021
Q4 | $15.6M | Buy |
655,717
+25,150
| +4% | +$598K | ﹤0.01% | 2128 |
|
2021
Q3 | $16M | Buy |
630,567
+111,593
| +22% | +$2.83M | ﹤0.01% | 2114 |
|
2021
Q2 | $11.7M | Buy |
518,974
+98,086
| +23% | +$2.21M | ﹤0.01% | 2350 |
|
2021
Q1 | $8.31M | Buy |
420,888
+120,311
| +40% | +$2.38M | ﹤0.01% | 2479 |
|
2020
Q4 | $7.99M | Buy |
300,577
+8,164
| +3% | +$217K | ﹤0.01% | 2312 |
|
2020
Q3 | $14.4M | Buy |
292,413
+266,887
| +1,046% | +$13.2M | ﹤0.01% | 1743 |
|
2020
Q2 | $806K | Buy |
+25,526
| New | +$806K | ﹤0.01% | 3210 |
|